Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean dimethoxy and zinc oxide?
Displaying drugs 14626 - 14650 of 15194 in total

2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID

Experimental

Rivoglitazone

Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
Experimental
Investigational

4SC-203

4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational

Tucaresol

Tucaresol has been used in trials studying the treatment of HIV Infections.
Investigational

Dipipanone

Experimental
Illicit

2,3,4,5,6-Pentafluorobenzyl Alcohol

Experimental

Balanol Analog 2

Experimental

N-[3-(aminomethyl)benzyl]acetamidine

Experimental

2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide

Experimental

Diethyl 4-Methylbenzylphosphonate

Experimental

Iodobenzene

Experimental

1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea

Experimental

ES-936

Experimental

AL7182

Experimental

1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane

Experimental

(R)-Bicalutamide

Experimental

S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea

Experimental

4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole

Experimental

4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

PAS219

Experimental

(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester

Experimental

FR239087

Experimental

4-Fluorophenethyl Alcohol

Experimental

Phenacetin

Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn

1,3,5-trichlorobenzene

Experimental
Displaying drugs 14626 - 14650 of 15194 in total